Reaching 100 is already rare. Reaching 110 is extraordinarily uncommon.
People known as supercentenarians give researchers an unusual opportunity to study healthy aging. Instead of simply asking why some people live longer, scientists can look at what appears to be different inside their bodies.
One of the most intriguing clues involves the immune system.
A 2019 study by researchers at RIKEN and Keio University found that people aged 110 and older had unusually high numbers of a specialized type of immune cell called cytotoxic CD4 T cells. The researchers analyzed blood cells from seven supercentenarians and compared them with cells from five people aged 50 to 80.
Now, newer research is adding another piece to the puzzle. A 2026 study from researchers including RIKEN scientists examined immune-cell data across ages from infancy into extreme old age and found that cytotoxic CD4 T cells remained relatively uncommon through the 90s but tended to increase after age 100. The researchers also found that these cells did not simply look exhausted, despite their advanced age.
That raises a fascinating question:
Could an unusually adaptable immune system be one reason some people remain resilient into extreme old age?
Aging Usually Changes the Immune System
As we grow older, our immune system changes.
The thymus, an organ involved in producing and training T cells, gradually becomes less active. The immune system also accumulates memory cells from decades of encounters with infections and other challenges.
This process, often discussed under the term immunosenescence, can make older adults more vulnerable to some infections and reduce the body’s ability to respond to new threats.
That is one reason illnesses such as influenza, respiratory infections and other infections can be more serious in later life.
But supercentenarians appear to challenge the idea that immune aging follows exactly the same pattern in everyone.
Their immune systems may not simply be “younger.” Instead, researchers are finding signs that the immune system can reorganize itself.
Meet the Unusual CD4 Killer Cells
T cells are a major part of the adaptive immune system.
Traditionally, CD4 T cells are known primarily for helping coordinate immune responses. CD8 T cells, meanwhile, are better known for directly killing infected or abnormal cells.
The supercentenarian research revealed something more unusual.
Some CD4 T cells in these exceptionally old individuals had acquired cytotoxic, or cell-killing, characteristics. They expressed molecules including granzyme B that are associated with the ability to attack target cells.
The researchers also found evidence of clonal expansion.
In simple terms, many of these cells appeared to be descendants of a smaller number of original T cells that had multiplied over time.
That suggests the immune system of some supercentenarians may have repeatedly selected and expanded particular immune-cell populations.
But scientists do not yet know exactly what these cells are responding to.
Why Would the Body Need More “Killer” Cells?
There are several possibilities.
One is immune surveillance.
Every person’s cells accumulate changes over a lifetime. The immune system constantly monitors the body for cells that look abnormal or dangerous.
Cytotoxic immune cells can help eliminate infected cells and certain abnormal cells before they become a larger problem.
Researchers have therefore proposed that the unusual CD4 T-cell population found in supercentenarians may contribute to protection against some infections or tumors. However, this remains a hypothesis rather than proof that these cells are responsible for exceptional longevity.
Another possibility is that these cells reflect a lifetime of exposure to particular infections.
In other words, they could be part of the reason some people remain healthy—or they could be a biological record of the challenges those people successfully survived.
The distinction is important.
The New 2026 Finding Makes the Story Even More Interesting
The latest research helps put the original discovery into perspective.
Rather than looking only at a handful of very old people, researchers combined single-cell data from centenarians with larger publicly available datasets covering people from very young ages through extreme old age.
They found that cytotoxic CD4 T cells generally remained at low levels through the 90s and then increased during the 100s. The study also reported that the expanded cells did not show the expected signs of severe exhaustion and retained diverse cytokine responses.
That does not mean that becoming 100 automatically causes these cells to appear.
Instead, the finding suggests that immune remodeling may be part of extreme aging.
The immune system may continue adapting even when the body has reached an age at which many other biological systems have experienced substantial decline.
This Is Not a Longevity Treatment—Yet
It is tempting to look at findings like these and immediately ask whether scientists could create a treatment that increases cytotoxic CD4 T cells.
That possibility is interesting, but it is much too early to draw that conclusion.
The original study involved only seven supercentenarians and five comparison participants.
And even the newer research does not establish that these cells cause people to live longer.
There may be many reasons why someone reaches 110.
Genetics, cardiovascular health, metabolism, immune function, environment, access to healthcare and plain biological luck can all contribute.
The immune system is likely just one piece of a much larger puzzle.
What This Means for Older Adults Today
The research does not provide a pill, diet or supplement that can reproduce the immune profile of a supercentenarian.
That is actually an important message.
For older adults, the practical goal should not be trying to copy one unusual immune-cell population. It should be protecting the overall health of the immune system through established medical care.
That includes staying up to date with recommended vaccinations, maintaining regular physical activity appropriate for your abilities, eating a varied nutritious diet, getting adequate sleep and managing chronic conditions with your healthcare team.
These measures are supported by far more evidence for healthy aging than attempts to manipulate individual immune-cell populations.
The Bigger Lesson About Growing Older
Perhaps the most fascinating lesson from supercentenarian research is that aging may be less predictable than we once thought.
The body does not simply switch from “healthy” to “old.”
Even at 100 or 110, cells can adapt, populations can change and biological systems can reorganize.
The discovery of cytotoxic CD4 T cells is therefore not proof of an immortality mechanism. It is something more useful: a clue.
Scientists are beginning to see that people who survive into extreme old age may possess immune systems that have adapted in distinctive ways.
Understanding those adaptations could eventually help researchers develop better strategies for protecting immune function and health in ordinary older adults.
For now, the message is both fascinating and reassuring.
Getting older does not necessarily mean every part of the immune system simply stops working. Sometimes, the body appears to find new ways to defend itself.
Photo by Andrea Piacquadio: https://www.pexels.com/photo/man-in-blue-jacket-holding-green-plants-and-red-apple-3782147/